The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.
Open accessAbstract
Enzyme replacement has been under consideration as a therapeutic strategy for patients with Gaucher disease for more than two decades. Previous studies indicated that single injections of purified glucocerebrosidase reduced the amount of storage material in the liver. It was important to determine whether administration of exogenous enzyme on a regular basis would be of clinical benefit. We report here that weekly i.v. infusions of a macrophage-targeted preparation of human placental glucocerebrosidase in a child with type 1 Gaucher disease increased hemoglobin from 6.9 +/- 0.8 g/dl (+/- 1 SD) to 10.2 +/- 0.4 g/dl (+/- 1 SD) over a 20-week period. The platelet count also increased from a pretreatment value of 30,000 +/- 7000/mm3 (+/- 1 SD) to 54,000 +/- 11,000/mm3 (+/- 1 SD). Phagocytic activity in the spleen decreased during the period of enzyme administration, and there was radiographic evidence of skeletal improvement. These observations document objective clinical responses to enzyme supplementation in a patient with a sphingolipid storage disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Casella, G., & Berger, R. (2024) · Chapman & Hall/CRC eBooks · doi:10.1201/9781003456285 · Cited by 5,711
Stahl, P. D., Rodman, J. S., Miller, M. J., & Schlesinger, P. H. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.3.1399 · Cited by 590
Brady, R. O., Pentchev, P. G., Gal, A. E., Hibbert, S. R., & Dekaban, A. S. (1974) · New England Journal of Medicine · doi:10.1056/nejm197411072911901 · Cited by 294
Self-citationDiagnosis of Gaucher's Disease and Niemann-Pick Disease with Small Samples of Venous Blood
Kampine, J. P., Bardy, R. O., Kanfer, J. N., Feld, M., & Shapiro, D. (1967) · Science · doi:10.1126/science.155.3758.86 · Cited by 286
Furbish, F. S., Steer, C. J., Krett, N. L., & Barranger, J. A. (1981) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(81)90474-8 · Cited by 186
Self-citationBrady, R. O. (1966) · New England Journal of Medicine · doi:10.1056/nejm196608112750606 · Cited by 152
Self-citationFurbish, F. S., Blair, H. E., Shiloach, J., Pentchev, P. G., & Brady, R. O. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.8.3560 · Cited by 134
Self-citationTakasaki, S., Murray, G. J., Furbish, F. S., Brady, R. O., Barranger, J. A., & Kobata, A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90936-1 · Cited by 131
Self-citationTsuji, S., Choudary, P. V., Martin, B. M., Winfield, S. L., Barranger, J. A., & Ginns, E. I. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42428-8 · Cited by 129
Cited by
Barton, N. W., Brady, R. O., Dambrosia, J. M., Di Bisceglie, A. M., Doppelt, S. H., Hill, S. C., Mankin, H. J., Murray, G. J., Parker, R. I., Argoff, C. E., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105233242104 · Cited by 1,252
Self-citationAsano, N., Nash, R. J., Molyneux, R. J., & Fleet, G. W. J. (2000) · Tetrahedron: Asymmetry · doi:10.1016/s0957-4166(00)00113-0 · Cited by 1,015
van der Ploeg, A. T., & Reuser, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61555-x · Cited by 756
Glycosidase inhibitors: update and perspectives on practical use
Asano, N. (2003) · Glycobiology · doi:10.1093/glycob/cwg090 · Cited by 715
Physiology and pathophysiology of sphingolipid metabolism and signaling
Huwiler, A., Kolter, T., Pfeilschifter, J., & Sandhoff, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00042-1 · Cited by 432
Metadata
- Authors
- Barton, N. W., Furbish, F. S., Murray, G. J., Garfield, M., & Brady, R. O.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1990-03
- Volume
- 87
- Issue
- 5
- Pages
- 1913-1916
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2078379563
- Cited by
- 366
- References
- 9
- FWCI
- 12.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.